These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8751102)

  • 21. Botulinum toxin type A purified neurotoxin complex for the treatment of blepharospasm: a dose-response study measuring eyelid force.
    Iwashige H; Nemeto Y; Takahashi H; Maruo T
    Jpn J Ophthalmol; 1995; 39(4):424-31. PubMed ID: 8926651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blepharospasm and hemifacial spasm: a protocol for titration of botulinum toxin dose to the individual patient and for the management of refractory cases.
    Ortisi E; Henderson HW; Bunce C; Xing W; Collin JR
    Eye (Lond); 2006 Aug; 20(8):916-22. PubMed ID: 16531977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of blepharospasm and hemifacial spasm with botulinum A toxin].
    Dai Z
    Zhonghua Yan Ke Za Zhi; 1993 May; 29(3):144-5. PubMed ID: 8223038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical technique for patients with the apractic type of essential blepharospasm: case report.
    Smet H; De Wilde F; Tassignon MJ
    Bull Soc Belge Ophtalmol; 1994; 254():85-8. PubMed ID: 7493130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin.
    Neubrand M; Scheurlen C; Schepke M; Sauerbruch T
    Endoscopy; 2002 Jul; 34(7):519-23. PubMed ID: 12170400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of idiopathic blepharospasm with botulinum toxin A].
    Toczołowski J; Romaniuk W; Wróblewska E; Stelmasiak Z; Lewandowska-Furmanik M
    Klin Oczna; 1994 Mar; 96(3):95-6. PubMed ID: 8090009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of botulinum toxin injection for achalasia in Thai patients.
    Leelakusolvong S; Sinpeng T; Pongprasobchai S; Tanwandee T; Kachintorn U; Manatsathit S
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S67-72. PubMed ID: 17718248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hemifacial spasm treated with botulinum toxin].
    Jedynak CP; Palfi S; Vidailhet M; Kullmann B
    Rev Neurol (Paris); 1993; 149(3):202-6. PubMed ID: 8235213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period.
    Hsiung GY; Das SK; Ranawaya R; Lafontaine AL; Suchowersky O
    Mov Disord; 2002 Nov; 17(6):1288-93. PubMed ID: 12465070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosage changes in patients with long-term botulinum toxin use for laryngeal dystonia.
    Birkent H; Maronian N; Waugh P; Merati AL; Perkel D; Hillel AD
    Otolaryngol Head Neck Surg; 2009 Jan; 140(1):43-7. PubMed ID: 19130960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of blepharospasm.
    Waller RR; Kennedy RH; Henderson JW; Kesty KR
    Trans Am Ophthalmol Soc; 1985; 83():367-86. PubMed ID: 3832534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxin for people with dystonia treated by an outreach nurse practitioner: a comparative study between a home and a clinic treatment service.
    Whitaker J; Butler A; Semlyen JK; Barnes MP
    Arch Phys Med Rehabil; 2001 Apr; 82(4):480-4. PubMed ID: 11295008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Supramaximal doses of botulinum toxin for refractory blepharospasm.
    Levy RL; Berman D; Parikh M; Miller NR
    Ophthalmology; 2006 Sep; 113(9):1665-8. PubMed ID: 16828511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pretarsal application of botulinum toxin for treatment of blepharospasm.
    Aramideh M; Ongerboer de Visser BW; Brans JW; Koelman JH; Speelman JD
    J Neurol Neurosurg Psychiatry; 1995 Sep; 59(3):309-11. PubMed ID: 7673963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group].
    Wissel J; Müller J; Heinen F; Mall V; Sojer M; Ebersbach G; Poewe W
    Wien Klin Wochenschr; 1999 Oct; 111(20):837-42. PubMed ID: 10586488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcome and predictor variables in the treatment of acquired esotropia with botulinum toxin.
    Tejedor J; Rodríguez JM
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2542-6. PubMed ID: 11581195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical and therapeutic aspects of essential blepharospasm].
    Russegger L; Grunert V
    Nervenarzt; 1989 Jul; 60(7):401-6. PubMed ID: 2761660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Torticollis treated with botulinum toxin].
    Wulff CH; Dupont E
    Ugeskr Laeger; 1993 Feb; 155(5):284-9. PubMed ID: 8446996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
    Schmid DM; Sauermann P; Werner M; Schuessler B; Blick N; Muentener M; Strebel RT; Perucchini D; Scheiner D; Schaer G; John H; Reitz A; Hauri D; Schurch B
    J Urol; 2006 Jul; 176(1):177-85. PubMed ID: 16753396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does Botulinum toxin have a role in the treatment of small-angle esotropia?
    Dawson EL; Lee JP
    Strabismus; 2004 Dec; 12(4):257-60. PubMed ID: 15545143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.